Resources Contact Us Home
Antisense oligonucleotides targeted to human CDC45

Image Number 4 for United States Patent #7393950.

Antisense oligonucleotides that inhibit expression of human replication-initiation protein as well as methods of preventing or treating hyperproliferative conditions using said oligonucleotides are disclosed. One aspect provides an antisense oligonucleotides that inhibits the expression of human replication-initiation protein and has a sequence complementary to at least a portion of a target sequence encoding a human replication-initiation gene. By administering a therapeutically effective amount of antisense oligonucleotides or by contacting the hyperproliferating cells with an effective amount of antisense oligonucleotides, expression of replication-initiation protein is inhibited. Methods of screening and testing active antisense oligonucleotides for their ability to inhibit gene expression are also disclosed.

  Recently Added Patents
Deceleration dependent shift control
Electronic multiparty accounts receivable and accounts payable system
Silicon-on-insulator (SOI) structure configured for reduced harmonics and method of forming the structure
Apparatus for focus beam analysis of high power lasers
Linked area parameter adjustment for spinal cord stimulation and associated systems and methods
  Randomly Featured Patents
Side entry fish pump
Verbascum plant named `Sierra Sunset`
Vehicle wheel retention system
Method for fabricating a power semiconductor device having a floating island voltage sustaining layer
System and method for hardening rails
Combined washing machine and drying machine
Using digital certificates to facilitate enforcement of product licenses
Optical waveguide having low optical damage
Passive seat belt system